The Scilligence Weekly Issue No. 18
eGenesis, a Cambridge-based startup, is addressing the shortage of available organs for transplant by developing effective human transplantable organs using CRISPR technology to modify pig organs.
Read More
Are you curious about the relationship between genetics and memory, attention, and reaction speed? Online brain game company, Lumosity, and George Church’s Harvard research team have joined together to explore genetics and memory with potential to lead to groundbreaking technologies in understanding diseases like Alzheimer’s.
Read More
Neurovance, a Cambridge-based pharmaceutical company has been acquired by Otsuka Pharmaceuticals. Neurovance is a clinical stage pharmaceutical company focused on attention-deficit hyperactivity disorder (ADHD) in children and adults.
Read More
Researchers find correlations between diabetes and cancer and how the type II diabetes drug, Metformin treats them both.
Read More
Cambridge-based Seres Therapeutics plans to test potentially breakthrough microbiome drug, SER-109. If successful, SER-109 could go on to treat bacterial infection Clostridium difficile, which can occur as a result of using antibiotics.
Read More
Jobs
Associate Scientist – Fulcrum Therapeutics, Cambridge, MA
Job Site
Senior Scientist – Pharmacology – Ironwood Pharmaceuticals, Cambridge, MA
Job Site
Bioinformatics Analyst – Brigham & Women’s Hospital, Boston, MA
Job Site